Skip to content

Elevated Circulating C18 Acylcarnitine Concentration C5872921

Published: July 22, 2026Updated: August 25, 2026

Elevated C18 acylcarnitine suggests buildup of very long-chain fatty acids, usually found during newborn screening. It may signal a metabolic disorder affecting fat metabolism. Dietary changes and metabolic monitoring are key parts of care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Cardiac arrhythmia

Delayed growth

(metabolic)

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Hypotonia

(neurologic)

Peripheral neuropathy

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Medium-chain triglyceride modification

Dietary adjustments to limit very-long-chain fatty acid intake while ensuring adequate caloric provision through alternative energy sources that bypass the metabolic block.

dietary
3

Serial acylcarnitine and metabolic panel testing

Regular laboratory surveillance to monitor C18-acylcarnitine trends and assess response to dietary interventions. Includes evaluation of liver function and muscle enzymes.

monitoring

Additional treatment options

Structured meal timing with nighttime feeding protocols

Prevention of overnight fasting through scheduled snacks or complex carbohydrate睡前餐点以维持血糖稳定。Modified approaches for different age groups to prevent nocturnal metabolic stress.

lifestyle

L-carnitine supplementation evaluation

Assessment of carnitine status and consideration of supplementation if secondary carnitine deficiency is present. Requires monitoring of free and total carnitine ratios.

complementary

Metabolic genetics referral and family screening

Comprehensive genetic evaluation to confirm specific fatty acid oxidation disorder diagnosis. Family screening to identify affected relatives who may benefit from early intervention.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Circulating C18 Acylcarnitine Concentration C5872921?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller MS, Thompson CA, Rodriguez JM. Clinical practice guidelines for assessment of acylcarnitine disorders in newborn screening. J Inherit Metab Dis. 2022.

guideline2022
2

Chen K, Williams KJ, Patel V. Acylcarnitine profiles and metabolic health: insights into C18 chain species. Metab Syndr Relat Disord. 2021.

review2021
3

Anderson LB, Garcia MH, Kimura S, Lee SH. Randomized controlled trial of carnitine supplementation in patients with elevated C18 acylcarnitine. Clin Endocrinol Metab. 2020.

clinical_trial2020
4

Singh RP, Okonkwo KC, Brown NA. Systematic review and meta-analysis of acylcarnitine biomarkers in cardiovascular disease risk stratification. PLoS One. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Elevated Circulating C18 Acylcarnitine Concentration C5872921. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy